Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Unrelated Donor Transplants

Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study

Bone Marrow Transplantation volume 27, pages 27–33 (2001)Cite this article

Abstract

We compared the outcomes in patients receiving unrelated peripheral blood stem cell transplants (PBSCT) with those receiving bone marrow transplants (BMT) in a matched pair analysis. Seventy-four patients with hematological malignancies with HLA-matched (77%) and mismatched (23%) donors were analyzed in this study. Thirty-four patients (45%) were considered as high risk patients. Sixty-eight patients received standard conditioning regimens with Bu/Cy or TBI/Cy. Six patients received an intensified conditioning regimen with the addition of etoposide, thiotepa or melphalan. GVHD prophylaxis consisted of prednisolone, cyclosporine and methotrexate. Groups were matched for patient, donor, transplant characteristics and HLA compatibility. Peripheral blood stem cell collection led to the collection of a higher number of CD34+ and CD3+ cells in comparison to bone marrow collection. Leukocyte engraftment in the PBSCT group occurred in 14 days (median; range 6–26 days) and in the BMT group in 19 days (range 9–29 days; P < 0.02). The time of platelet engraftment did not differ significantly. The incidence of grades II–lV acute GVHD in the group of HLA-identical patients was 35% in the PBSCT group and 25% in the BMT group (P < 0.33, log-rank). However, there was a significant difference (P < 0.05, log-rank) in incidence and time to onset of acute GVHD II–IV comparing all patients, including the 17 mismatched transplants. Disease-free survival was 51% (19 patients) with a median of 352 days and 59% (21 patients) with a median of 760 days for PBSC and BMT transplants, respectively. In conclusion, our results indicate that allogeneic PBSCT led to significantly faster leukocyte engraftment but is associated with a higher incidence and more rapid onset of severe acute GVHD comparing all patients, including the 17 mismatched transplants. However, the incidence of severe acute GVHD in HLA-identical patients was not different between the PBSCT and BMT groups. Bone Marrow Transplantation (2001) 27, 27–33.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T cell-depleted hematopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia Bone Marrow Transplant 1989 4: 643–646

    CAS  PubMed  Google Scholar 

  2. Schmitz N, Bacigalupo A, Labopin M et al. Transplantation of allogeneic peripheral blood progenitor cells – the EBMT experience Bone Marrow Transplant 1996 17: (Suppl. 2) 40–46

    Google Scholar 

  3. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease Blood 1995 86: 2842–2848

    PubMed  Google Scholar 

  4. Russell JA, Brown C, Bowen T et al. Allogeneic blood cell transplants for haematological malignancy: preliminary comparison of outcomes with bone marrow transplantation Bone Marrow Transplant 1996 17: 703–708

    CAS  PubMed  Google Scholar 

  5. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood progenitor cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation Blood 1996 88: 2794–2800

    CAS  PubMed  Google Scholar 

  6. Ottinger HD, Beelen DW, Scheulen B et al. Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow Blood 1996 88: 2775–2779

    CAS  PubMed  Google Scholar 

  7. Sierra J, Storer B, Hansen JA et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemia burden, donor HLA-matching, and marrow cell dose Blood 1997 89: 4226–4235

    CAS  PubMed  Google Scholar 

  8. Urbano-Ispizua A, Solano C, Brunet S et al. Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases Bone Marrow Transplant 1996 18: 35–40

    CAS  PubMed  Google Scholar 

  9. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease Blood 1997 90: 4705–4709

    CAS  PubMed  Google Scholar 

  10. Scott MA, Gandhi MK, Jestice HK et al. A trend towards an increased incidences of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study Bone Marrow Transplant 1998 22: 273–276

    Article  CAS  Google Scholar 

  11. Bensinger W, Martin P, Clift R et al. A prospective, randomized trail of peripheral blood stem cell (PBSC) transplants or marrow (BM) for patients undergoing allogeneic transplantation for hematologic malignancies Blood 1999 10: (Suppl. 1) 368a (Abstr. 1637)

    Google Scholar 

  12. Durant S . Morton AJ. A randomized trial of filgrastim (G-CSF) stimulated donor marrow (BM) versus peripheral blood (PBSC) for allogeneic transplantation: increased extensive chronic GVHD following PBSC transplantation Blood 1999 10: (Suppl. 1) 608a (Abstr. 2706)

    Google Scholar 

  13. Anderlini P, Przepiorka D, Körbling M, Champlin R . Blood stem cell procurement: donor safety issues Bone Marrow Transplant 1998 21: (Suppl. 3) 35–39

    Google Scholar 

  14. Bensinger WI, Price TH, Dale DC et al. The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis Blood 1998 81: 1883–1888

    Google Scholar 

  15. Becker PS, Wagle M, Matous S et al. Spontaneous splenic rupture following administration of granulocyte colony stimulating factor (G-CSF): occurence in an allogeneic donor of peripheral blood stem cells Blood Marrow Transplant 1997 3: 45–49

    CAS  Google Scholar 

  16. Basara N, Blau IW, Kiehl MG et al. Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients Clin Transplant 2000 14: 121–126

    Article  CAS  Google Scholar 

  17. Hägglund H, Ringden O, Remberger M et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival using peripheral blood stem cells from related and unrelated donors, compared to bone marrow Bone Marrow Transplant 1998 22: 131–136

    Article  Google Scholar 

  18. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. Parts I, II New Engl J Med 1975 293: 832–840, 895–902

    Article  Google Scholar 

  19. Przepiorka D, Weisdorf D, Martin P et al. Meeting report: concensus conference on acute GVHD grading Bone Marrow Transplant 1995 15: 825–828

    CAS  PubMed  Google Scholar 

  20. Shulman HM, Sullivan KM, Weiden PI et al. Chronic graft-versus-host syndrome in man. A long term clinicopathologic study of 20 Seattle patients Am J Med 1980 69: 204–217

    Article  CAS  Google Scholar 

  21. Peto R, Pike MC, Armitage P et al. Design and analysis of randomized clinical trails requiring prolonged observation of each patient. II. Analysis and examples Br J Cancer 1977 35: 1–39

    Article  CAS  Google Scholar 

  22. Armitage P, Berry G . Statistical Methods in Medical Research Blackwell Science: Oxford 1987

    Google Scholar 

  23. Ringden O, Lönnqvist B, Hägglind H et al. Transplantation with peripheral blood stem cells from unrelated donors without serious graft-versus-host disease Bone Marrow Transplant 1995 16: 856–857

    CAS  PubMed  Google Scholar 

  24. Blaise D, Kuentz M, Fortanier C et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Française de Greffe de Moelle J Clin Oncol 2000 18: 537–546

    Article  CAS  Google Scholar 

  25. Schmitz N, Bacigalupo A, Hasenclever D et al. Allogeneic bone marrow transplantation vs filgrastim-mobilized peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomized multicenter trial of the European group for Blood and Marrow Transplantation Bone Marrow Transplant 1998 21: 995–1003

    Article  CAS  Google Scholar 

  26. Ringden O, Remberger M, Runde V et al. Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation Blood 1999 94: 455–464

    CAS  PubMed  Google Scholar 

  27. Stockschläder M, Löliger C, Krüger W et al. Transplantation of allogeneic rhG-CSF mobilized peripheral CD34+ cells from an HLA-identical unrelated donor Bone Marrow Transplant 1995 16: 719–722

    PubMed  Google Scholar 

  28. Pan L, Delmonte J Jr, Jalonen C et al. Pretreatment of donor mice with granulocyte colony stimulating factor polarizes donor T-lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host-disease Blood 1995 86: 4422–4429

    CAS  PubMed  Google Scholar 

  29. Tayebi H, Tiberghien P, Kuentz M et al. Comparison of HLA-identical allogeneic bone marrow (BM) versus peripheral blood stem cells (PBSC) transplantation: phenotypical and functional study of donor T cells in the graft and after hematopoietic reconstitution Blood 1998 92: 140 (Abstr. 562)

    Google Scholar 

  30. Anderlini P, Körbling M, Dale D et al. Allogeneic blood stem cell transplantation: considerations for donors Blood 1997 90: 903–908

    CAS  PubMed  Google Scholar 

  31. Storek J, Dawson M, Maloney DG . Normal T,B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting (letter) Blood 2000 95: 2993–2994

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinic for Bone Marrow Transplantation, Hematology and Oncology, Idar-Oberstein, Germany

    IW Blau, N Basara, G Lentini, S Guenzelmann, D Kirsten, B Schmetzer, M Bischoff, E Roemer, MG Kiehl & AA Fauser

Authors
  1. IW Blau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Basara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Lentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Guenzelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Kirsten
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Schmetzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M Bischoff
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E Roemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. MG Kiehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. AA Fauser
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blau, I., Basara, N., Lentini, G. et al. Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study. Bone Marrow Transplant 27, 27–33 (2001). https://doi.org/10.1038/sj.bmt.1702734

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702734

Keywords

This article is cited by

Search

Advanced search

Quick links